Author

E. Triantafyllou

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:cell type annotation· 2 Research Focus:cell-cell communication· 2 Research Focus:differential expression· 2 Organism:human· 2 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

E. Mitchell· 2 shared L. A. Possamai· 2 shared A. Geng· 1 shared A. P. Costa-Pereira· 1 shared A. P. Siskos· 1 shared A. Singanayagam· 1 shared C. Aguirre Hernandez· 1 shared C. Balcells· 1 shared

Activity by Year

2023-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

E. Mitchell

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Targeting the expansion of myeloid-derived suppressor cells in liver cirrhosis

E. E. Flint, C. Ercan, E. Mitchell, O. T. Pop, A. Geng, P. Jorzik, L. A. Possamai, R. G. Brenig, S. Morel, P. Sieber, A. Singanayagam, M. S. Matter, D. Semela, M. H. E. Heim, P. Demougin, , C. Bernsmeier

This study investigates MDSC expansion in cirrhosis patients and murine models, showing poly(I:C) reduces MDSC and fibrosis in infected fibrotic mice.

bioRxiv · Mar 29, 2024 · PreprintImmunology

Therapeutic inhibition of monocyte recruitment prevents checkpoint inhibitor-induced hepatitis

C. L. C. Gudd, S. R. Atkinson, E. Mitchell, M.-A. Mawhin, S. Turajlic, J. Larkin, M. R. Thursz, R. D. Goldin, N. Powell, C. G. Antoniades, K. J. Woollard, L. A. Possamai, E. Triantafyllou

This paper develops a mouse model to study CPI-hepatitis and shows that inhibiting CCR2+ monocyte recruitment prevents liver damage caused by checkpoint inhibitors.

bioRxiv · Aug 14, 2023Immunology

Heme oxygenase-1 expressing omental macrophages as a therapeutic target in ovarian high grade serous carcinoma

S. Spear, O. Le Saux, H. B. Mirza, K. Tyson, J. Bickel, F. Grundland Freile, A. P. Siskos, C. Balcells, J. B. Walton, C. Woodman, D. P. Ennis, N. Iyer, C. Aguirre Hernandez, Y. Xu, P. Spiliopoulou, , I. A. McNeish

This study identifies HMOX1-expressing omental macrophages as a therapeutic target and biomarker for poor prognosis ovarian high-grade serous carcinoma.

bioRxiv · Jul 18, 2023 · PreprintCancer Biology